Search Results for "anecdote"
Except for presidential anecdote, NBC story on new melanoma drug was well-balanced
By including a discussion of costs, harms, and alternatives, readers are left with a pretty good idea of what this new intervention is about.
Cancer Drug Keytruda Keeps Some Patients Alive For 3 Years
Personal anecdotes overwhelm cautionary details in WSJ story on ayahuasca, a Peruvian hallucinogenic concoction
At least one personal account of the harms would have brought the story into better balance.
Is Peru’s Psychedelic Potion a Cure or a Curse?
Globe story on experimental autism treatment is all anecdote, no data
This story had no data, no broader perspective, no independent voices, no pushback at all on the claims made. For readers hopeful to read about a new autism treatment, all of this is important.
Tracking the risks and rewards of transcranial magnetic stimulation
‘Baby deadline test’ story on NBC News: heavy on anecdotes, light on evidence
This story describes how some doctors are helping women “beat their biological clock” by taking a test that roughly predicts the number of eggs left in the ovaries. This piece was rife with problems–from disease-mongering to skipping any discussion of data.
Baby Deadline Test: Beat Your Biological Clock
False balance in CNN coverage of female sexual dysfunction: anecdotes given equal weight as systematic evidence review
This story doesn’t help readers discern between two forms of evidence that should carry vastly different amount of weight in readers’ minds. It also doesn’t alert readers to an expert source’s potential conflicts of interest.
'Female Viagra' gets mixed reviews
ADHD treatment news via lone anecdote more advertising than journalism
Riding a single anecdote, this story could easily raise false hopes in parents of children with autism, attention-deficit hyperactivity disorder and other diagnoses. Single-source single-anecdote stories do not make good health care journalism.
When medication doesn't work: Innovative program eases ADHD symptoms naturally
Excellent sourcing, but questionable anecdotes, for WSJ piece on same-day hip replacement
Despite many expert opinions and patient voices in this story, we were left wanting more from the coverage.
Same-Day Hip Replacement
Bold claims for migraine treatment are based on opinions and anecdote in this story
This story says there is no “magic pill” for migraines, and yet it offers something of a magic pill in the headline by saying that lifestyle changes can relieve symptoms. Maybe it’s true, but there is no evidence presented to back up the assertion.
For Headaches, A Lifestyle Change May Be Better Than A Doctor Visit
Thoughtful and thorough, AP story looks at growing trend of using ketamine for depression
When it comes to ketamine, people with depression and their families should be informed of the unclear benefits and risks.
High hopes & hype for experimental depression drug ketamine
One woman’s account of spinal cord stimulator skips realities of medical device safety in U.S.
The story also did not mention that the author acknowledged being a paid “advocate” for pain patients, which could present a conflict of interest.
Here’s how one woman used an implant to get some relief from chronic back pain
Genetic testing to guide antidepressant choices: Big news coverage, but limited evidence
The evidence cited here is still very preliminary, a finding we also noticed in another recently reviewed article on using genetic testing for targeting depression meds.
Which antidepressant is right for you? This genetic test could help
BuzzFeed warns readers ‘a lot more work to be done’ to find out if experimental blood test can predict preterm birth
The story would have benefited from an outside expert weighing on the study and its potential ramifications and — more importantly — the potential harms of a false-positive test, which are not insignificant.
This Blood Test Could Help Predict If A Pregnancy Is At Risk For Premature Labor
NPR (yet again) writes uncritically about ketamine for mental illness
The story makes sweeping statements, without support, favoring the use of ketamine to treat a vast array of ills.
From Chaos To Calm: A Life Changed By Ketamine
Drug’s ability to lower frequency of migraines by 50 percent sounds pretty good–until you read the fine print
NBC News story doesn’t adequately scrutinize the claims being made about a new drug to prevent migraines.
FDA approves new drug that prevents migraines without side effects
Boston Globe overlooks evidence showing many patients not helped by ‘bionic’ joint replacements
This was amplified by the lack of specific data on benefits for patients, and the only expert quoted has a conflict of interest that wasn’t disclosed.